Cargando…
Cytocentric measurement for regenerative medicine
Any Regenerative Medicine (RM) business requires reliably predictable cell and tissue products. Regulatory agencies expect control and documentation. However, laboratory tissue production is currently not predictable or well-controlled. Before conditions can be controlled to meet the needs of cells...
Autores principales: | Henn, Alicia D., Pereira, Taci, Hunsberger, Joshua, Mitra, Kunal, Izadifar, Zohreh, Somara, Sita, Lindström, Lisa, Forest Farb-Horch, Thomas, Boy, Jake, Muschler, George F., Bauer, Steven R., Yerden, Randy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172495/ https://www.ncbi.nlm.nih.gov/pubmed/37181099 http://dx.doi.org/10.3389/fmedt.2023.1154653 |
Ejemplares similares
-
Regenerative Technologies: Future Grand Challenges and Emerging Strategies
por: Cartmell, Sarah H.
Publicado: (2020) -
Regen med therapeutic opportunities for fighting COVID‐19
por: Atala, Anthony, et al.
Publicado: (2020) -
Functionalized Nanoparticles: A Paradigm Shift in Regenerative Endodontic Procedures
por: Subramaniam Ramachandran, Vinoo, et al.
Publicado: (2022) -
3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries
por: Ramadan, Qasem, et al.
Publicado: (2021) -
Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing
por: Leighton, Jake, et al.
Publicado: (2022)